Eris Lifesciences Limited (ERIS)
₹1,637.4
INR-14.40(-0.87%)
As of June 6, 2025 9:40:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹22495.04 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹25131.97 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
63.92
Forward P/E
Price to Earnings ratio based on forecasted earnings
39.66
PEG Ratio
Price/Earnings to Growth ratio
39.66
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
7.81
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
75.77%
Operating Margin
Operating income as a percentage of revenue
24.93%
Return on Equity
Net income as a percentage of shareholders' equity
11.54%
Revenue (TTM)
Total revenue over trailing 12 months
₹2879.26 Cr+28.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1035.62 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹25.84+32.2%
Balance Sheet
Total Cash
Total cash and short-term investments
₹227.83 Cr
Total Debt
Total short-term and long-term debt
₹2477.92 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
75.74%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹987.1 - ₹1664.3
Beta
Measure of stock's volatility compared to the market
NA
Shares Outstanding
Total number of shares issued by the company
₹13.62 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.92%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
28.48%
